Skip to content

Clinical trials

Phase 4 Heart Failure trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 4 Country / region: Poland Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20082
20091
20132
20141
20171
20181
20211
20222
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status7
Completed4
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Medical University of Warsaw3
Biotronik SE & Co. KG2
Clinical Hospital Heliodor Swiecicki of the Medical University of Karol Marcinkowski in Poznań1
Collegium Medicum w Bydgoszczy1
Dinesh Thavendiranathan1
Medical University of Silesia1
National Institute of Cardiology, Warsaw, Poland1
Novartis Pharmaceuticals1
Silesian Centre for Heart Diseases1
University of Zagreb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure15
Atrial Fibrillation2
Cardiotoxicity2
Breast Diseases1
Breast Neoplasms1
Cardiomyopathies1
Cardiomyopathy, Dilated1
Cardiovascular Diseases1
Death, Sudden, Cardiac1
Diabetes Mellitus, Type 21

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.